Role of human parvovirus B19 in the pathogenesis of rheumatoid arthritis

Japanese Journal of Infectious Diseases

Volumn 52, Issue 5, 1999, Pages 201-207

  Ishii, Keiko Kumura ^a   Takahashi, Yuichi ^a   Kaku, Mitsuo ^a   Sasaki, Takeshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNOPATHOLOGY; PARVOVIRUS; PATHOGENESIS; PERSISTENT INFECTION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PROSPECTIVE STUDIES; SYNOVIAL MEMBRANE;

EID: 0342905399     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Harris, E. D., Jr. (1990): Rheumatoid arthritis: pathophysiology and implications for therapy. N. Eng. J. Med., 322, 1277-1289.
2. Firestein, G. S., Alvaro-Garcia, J. M. and Maki, R. (1990): Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol., 144, 3347-3353.
3. Remmers, E. F., Sano, H., Lafyatis, R., Case, J. P., Kumkumian, G. K., Hla, T., Maciag, T. and Wilder, R. L. (1991): Production of platelet derived growth factor B chain (PDGF-B/c-sis) mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: coexpression with heparin binding acidic fibroblast growth factor-1. J. Rheumatol., 18, 7-13.
4. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Einer, V. M., Elner, S. G. and Stricter, R. M. (1992): Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 258, 1798-1801.
5. Koch, A. E., Kunkel, S.L., Harlow, L. A., Johnson, B., Evanhoff, H. L., Kenneth Hains, G., Burdick, M. D., Pope, R. M. and Strieter, R. M. (1992): Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest., 90, 772-779.
6. Tetlow, L. C., Lees, M. and Woolley, D. E. (1995): Comparative studies, of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro. Virchows Arch., 425, 569-576.
7. Tetlow, L. C., Lees, M., Ogata, Y., Nagase, H. and Woolley, D. E. (1993): Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol. Int., 13, 53-59.
8. Jensen, H. S., Jensen, L. T., Sazne, T., Deamant, M. and Bendtzen, K. (1991): Human monocyte elastolytic activity, the propeptides of types I and III procollagen, proteoglycans, and interleukin-6 in synovial fluid from patients with arthritis. Clin. Exp. Rheumatol., 9, 391-394.
9. Alvaro-Gracia, J. M., Zvaifler, N. J. and Firestein, G. S. (1990): Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest., 86, 1790-1798.
10. 2 production by human synovial cells. J. Clin. Invest., 77, 645-648.
11. Krane, S. M., Conca, W., Stephenson, M. L., Amento, E. P. and Goldring, M.B. (1990): Mechanism of matrix degradation in rheumatoid arthritis. Ann. N. Y. Acad. Sci., 580, 340-354.
12. Firestein, G. S. (1996): Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum., 39, 1781-1790.
13. Janusz, M. J. and Hare, M. (1993): Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines: a model of metalloproteinase-mediated connective tissue degradation. J. Immunol., 150, 1922-1931.
14. Krause, A., Kamradt, T. and Burmester, G. R. (1996): Potential infectious agents in the induction of arthritides. Curr. Opin. Rheumatol., 8, 203-209.
15. Kingsley, G. (1997): Microbial DNA in the synovium-a role in aetiology or a mere bystander? Lancet, 349, 1038.
16. Kitajima, I., Yamamoto, K., Sato, K., Nakajima, Y., Nakajima, T., Maruyama, I., Osame, M. and Nishioka, K. (1991): Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J. Clin. Invest., 88, 1315-1322.
17. Iwakura, Y., Tosu, M., Yoshida, E., Takiguchi, M., Sato, K., Kitajima, I., Nishioka, K., Yamamoto, K., Takeda, T., Hatanaka, M., Yamamoto, H. and Sekiguchi, T. (1991): Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science, 253, 1026-1028.
18. Takei, M., Mitamura, K., Fujiwara, S., Horie, T., Ryu, J., Osaka, S., Yoshino, S. and Sawada, S. (1997): Detection of Epstein-Barr virus encoded small nuclear RNA-1 and latent membrane protein-1 in synovial lining cells from rheumatoid arthritis patients. Int. Immunol., 9, 739-743.
19. White, D. G., Woolf, A. D., Mortimer, P. P., Cohen, B. J., Blake, D. R. and Bacon, P. A. (1985): Human parvovirus arthropathy. Lancet, 1, 419-421.
20. Woolf, A. D., Campion, G. V., Chishick, A., Wise, S., Cohen, B. J., Klouda, P. T., Caul, O. and Dieppe, P. A. (1989): Clinical manifestations of human parvovirus B19 in adults. Arch. Intern. Med., 149, 1153-1156.
21. Murai, C., Munakata, Y., Takahashi, Y., Ishii, T., Shibata, S., Muryoi, T., Funato, T., Nakamura, M., Sugamura, K. and Sasaki, T. (1999): Rheumatoid arthritis after human parvovirus B19 infection. Ann. Rheum. Dis., 58, 130-132.
22. Takahashi, Y., Murai, C., Shibata, S., Munakata, Y., Ishii, T., Ishii, K., Saitoh, T., Sawai, T., Sugamura, K. and Sasaki, T. (1998): Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 95, 8227-8232.
23. Chorba, T., Coccia, P., Holman, R. C., Tattersall, P., Anderson, L. J., Sudman, J., Young, N. S., Kurczynski, E., Saarinen, U. M., Morir, R., Lawrence, D. N., Jason, J. M. and Evatt, B. (1986): Role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J. Infect. Dis., 154, 383-393.
24. Reid, D. M., Reid, T. M. S., Brown, T., Rennie, J. A. N. and Eastmond, C. J. (1985): Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet, I, 422-425.
25. Young, N. (1988): Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin. Hematol., 25, 159-172.
26. Anderson, L. J. (1990): Human parvovirus B19. Pediatrics Ann., 19, 509-513.
27. Frickhofen, N. and Young, N. S. (1989): Persistent parvovirus B19 infections in humans. Microb. Pathogen., 7, 319-327.
28. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L.A., Kaplan, S. R., Liang, M. H., Luthre, H. S., Medsger, T. A., Jr., Mitchell, D. M., Neustadt, D. H., Pinals, R. S., Schaller, J. G., Sharp, J. T., Wilder, R. L. and Hunder, G. G. (1988): The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 31, 315-324.
29. Luzzi, G. A., Kurtz, J. B. and Chapel, H. (1985): Human parvovirus arthropathy and rheumatoid factor. Lancet, I, 1218.
30. Cohen, B. J., Buckley, M. M., Clewley, J. P., Jones, V. E. and Puttick, A. H. (1986): Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann. Rheum. Dis., 45, 832-838.
31. Semble, E. L., Agudelo, C. A. and Pegram, P. S. (1987): Human parvovirus B19 arthropathy in two adults after contact with childhood erythema infectiosum. Am. J. Med., 83, 560-562.
32. Naides, S. J. and Field, E. H. (1988): Transient rheumatoid factor positivity in acute parvovirus B19 infection. Arch. Intern. Med., 148, 2587-2589.
33. Sasaki, T., Takahashi, Y., Yoshinaga, K., Sugamura, K. and Shiraishi, H. (1989): An association between human parvovirus B-19 infection and autoantibody production. J. Rheumatol., 16, 708-709.
34. Tyndall, A., Jelk, W. and Hirsh, H. H. (1994): Parvovirus B19 and erosive polyarthritis. Lancet, 343, 480-481.
35. Gran, J. T., Johnsen, V., Myklebust, G. and Norbdø, S. A. (1995): The variable clinical picture of arthritis induced by human parvovirus B19: report of seven adult cases and review of the literature. Scand. J. Rheumatol., 24, 174-179.
36. Nikkari, S., Roivainen, A., Hannonen, P., Möttötnen, T., Luukkainen, R., Yli-Jama, T. and Toivanen, P. (1995): Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann. Rheum. Dis., 54, 597-600.
37. Lefrere, J.-J., Meyer, O., Menkes, C-J., Beaulieu, M. J. and Courouce, A.-M. (1985): Human parvovirus and rheumatoid arthritis. Lancet, I, 982.
38. Saal, J. G., Steidle, M., Einsele, H., Müller, C. A., Fritz, P. and Zacher, J (1992): Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol. Int., 12, 147-151.
39. Kerr, J. R., Curran, M. D., Moore, J. E., Coyle, P. V., and Ferguson, W. P. (1995): Persistent parvovirus B19 infection. Lancet, 345, 1118.
40. Woolf, A. D. and Cohen, B. J. (1995): Parvovirus B19 and chronic arthritis-causal or casual association? Ann. Rheum. Dis., 54, 535-536.
41. Cohen, B. J. and Buckley, M. M. (1988): The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microbiol., 25, 151-153.
42. Söderlund, M., von Essen, R., Haapasaari, J., Kiistala, U., Kiviluoto, O. and Hedman, K. (1997): Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet, 349, 1063-1065.
43. Cassinotti, P., Siegel, G., Michel, B. A. and Brühlmann, P. (1998): Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J. Med. Virol., 56, 199-204.
44. Cassinotti, P., Schultze, D., Schlageter, P., Chevili, S. and Siegel, G. (1993): Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur. J. Clin. Microb. Infect. Dis., 12, 701-704.
45. Foto, F., Saag, K. G., Scharosch, L. L., Howard, E. J. and Naides, S. J. (1993): Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J. Infect. Dis., 167, 744-748.
46. Kerr, J. R., Cartron, J. P., Curran, M. D., Moore, J. E., Elliott, J. R. M. and Mollan, R. A. B. (1995): A study of the role of parvovirus B19 in rheumatoid arthritis. Br. J. Rheumatol., 34, 809-813.
47. Sasaki, T., Murai, C., Muryoi, T., Takahashi, Y., Munakata, Y., Sugamura, K. and Abe, K. (1995): Persistent infection of human parvovirus B19 in a normal subject. Lancet, 346, 851.
48. Cassinotti, P., Burtonboy, G., Fopp, M. and Siegel, G. (1997): Evidence for persistence of human parvovirus B19 DNA in bone marrow. J. Med. Virol., 53, 229-232.
49. Kurzman, G., Frickhofen, N., Kimball, J., Jenkins, D. W., Nienhuis, A. W. and Young, N. S. (1989): Pure red-cells aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Eng. J. Med., 321, 519-523.
50. Ozawa, K., Kurzman, G. and Young, N. (1986): Replication of the B19 parvovirus in human bone marrow cultures. Science, 233, 883-886.
51. Brown, K. E., Anderson, S. M. and Young, N. S. (1993): Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science, 262, 114-117.
52. von dem Borne, A. E. G., Bos, M. J. E., Joustra-Maas, N., Tromp, J. F., van Wijngaarden-du Bois, R. and Tetteroo, P. A. T. (1986): A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br. J. Haematol., 63, 35-46.
53. Cooling, L. L. W., Koerner, T. A. W. and Naides, S. J. (1995): Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J. Infect. Dis., 172, 1198-1205.
54. Kurzman, G. J., Gascon, P., Caras, M., Cohen, B. and Young, N. S. (1988): B19 parvovirus replicates in circulating cells of acutely infected patients. Blood, 71, 1448-1454.
55. Porter, H. J., Quantrill, A. M., Fleming, K. A. (1988): B19 parvovirus infection of myocardial cells. Lancet, I, 535-536.
56. Shimomura, S., Wong, S., Brown, K. E., Komatsu, N., Kajigaya, S. and Young, N. S. (1993): Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology, 194, 149-156.
57. Arend, W. P. and Dayer, J-M. (1995): Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum., 38, 151-160.
58. Moffatt, S., Tanaka, N., Tada, K., Nose, M., Nakamura, M., Muraoka, O., Hirano, T. and Sugamura, K. (1996): A cytotoxic nonstructural protein NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol., 70, 8485-8491.
59. Burmester, G. R., Stuhmüller, B., Keyszer, G. and Kinne, R. W. (1997): Mononuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis? Arthritis Rheum., 40, 5-18.
60. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D. and Kollias, G. (1991): Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J., 10, 4025-4031.
61. Elliott, M. J., Maini, R. N., Feldman, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J. and Woody, J. N. (1993): Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum., 36, 1681-1690.
62. Liu, J., Green, S., Shimada, T. and Young, N.S. (1992): A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J. Virol., 66, 4686-4692.
63. Moffatt, S., Yaegashi, N., Tada, K., Tanaka, N. and Sugamura, K. (1998): Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J. Virol., 72, 3018-3028.